Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer

Internal Medicine

Volumn 38, Issue 11, 1999, Pages 892-895

  Yamane, Hiromichi ^a   Bessho, Akihiro ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Katayama, Yoshio ^a   Motoda, Kinya ^a   Tsuchida, Tadashi ^a   Nogami, Naoyuki ^a   Hiraki, Akio ^a   Ueoka, Hiroshi ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation (auto PBSCT); Double transplantation

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGING; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; DOSE RESPONSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER METASTASIS; LUNG SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; VOMITING;

EID: 0032726889     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.892     Document Type: Article

References (23)

1. Kakizoe T. Cancer Statistics in Japan-1997, Foundation and Promotion of Cancer Research. National Cancer Center, Tokyo, 1997: 12-13.
2. Bunn PA Jr, Carney DN. Overview of chemotherapy for small cell lung cancer. Semin Oncol 24: S7-69-S7-74, 1997.
3. Norton L, Simon R. Tumor size, Sensitivity to chemotherapy, and design of treatment schedules. Cancer Treat Rep 61: 1307-1317, 1997.
4. Antman KH, Rowlings PA, Vaughan WP, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15: 1870-1879, 1997.
5. Rodenhuis S, Westermann A, Holtkamp MJ, et al. Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer. J Clin Oncol 14: 1473-1483, 1996.
6. Spitzer G, Farha G, Valdivieso M, et al. High-Dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma. J Clin Oncol 4: 4-13, 1986.
7. Humblet Y, Symann M, Bosly A, et al. Late Intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: A Randomized Study. J Clin Oncol 5: 1864-1873, 1987.
8. Elias AD, Ayash L, Frei III E, et al. Intensive combined modality therapy for limited-stage small-cell lung cancer. J Natl Cancer Inst 85: 559-566, 1993.
9. Ihde DC, Deisseroth AB, Lichter AS, et al. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small cell lung cancer. J Clin Oncol 4: 1443-1454, 1986.
10. Wolff SN, Johnson DH, Hande KR, et al. High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 67: 957-958, 1983 (letter).
11. Yano T, Katayama Y, Sunami K, et al. G-CSF induced mobolizalion of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF. Int J Hematol 66: 169-178, 1997.
12. Katayama Y, Yano Y, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 19: 283-287, 1997.
13. Fields KK,Elfenbein GJ, Perkins JB, et al. High-dose ifosfamide/ carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion. Semin Oncol 21: 86-92, 1994.
14. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982.
15. Sculier JP, Klastersky J, Stryckmans P, EORTC lung cancer working party (Belgium). Late intensification in small-cell lung cancer: A phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol 3: 184-191, 1985.
16. Souhami RL, Hajichristou HT, Miles DW, et al. Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. Cancer Chemother Phamacol 24: 321-325, 1989.
17. Brugger W, Frommhold H, Pressler K, et al. Use of high-dose etoposide/ ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Semin Oncol 22: 3-8, 1995.
18. Bitran JD, Samuels B, Klein L, et al. Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17: 157-162, 1996.
19. Ayash LJ, Elias A, Schwartz G, et al. Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: No Improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa and carboplatin. J Clin Oncol 14: 2984-2992, 1996.
20. Margolin K, Doroshow JH, Ahn C, et al. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol 14: 2631-2637, 1996.
21. Lotz JP, Bouleuc C, Andre T, et al. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma. Cancer 77: 2550-2559, 1996.
22. Shapiro CL, Ayash L, Webb LJ, et al. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients. J Clin Oncol 15: 674-683, 1997.
23. Long GD, Negrin RS, Hoyle CF, et al. Multiple cycles of high-dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies. Cancer 76: 860-868, 1995.